| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
24,270,000 |
| Market
Cap: |
516.22(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$20.03 - $40.81 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
29,577 |
54,115 |
78,957 |
| Total Sell Value |
$0 |
$791,434 |
$1,639,451 |
$2,902,369 |
| Total People Sold |
0 |
3 |
3 |
4 |
| Total Sell Transactions |
0 |
6 |
19 |
36 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bolger John C |
Director |
– • – |
2021-08-30 |
4 |
S |
$91.05 |
$85,449 |
D/D |
(936) |
2,000 |
|
7% |
|
| Bolger John C |
Director |
– • – |
2021-08-30 |
4 |
OE |
$3.93 |
$7,973 |
D/D |
936 |
2,312 |
|
- |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-08-30 |
4 |
S |
$91.25 |
$56,760 |
D/D |
(622) |
311,195 |
|
7% |
|
| Gao Hanlin |
Chief Scientific Officer |
• – – |
2021-08-16 |
4 |
S |
$95.12 |
$29,869 |
D/D |
(314) |
815,959 |
|
-7% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-08-16 |
4 |
S |
$95.12 |
$159,996 |
D/D |
(1,682) |
135,783 |
|
-7% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-08-16 |
4 |
S |
$95.12 |
$116,335 |
D/D |
(1,223) |
311,817 |
|
-7% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-08-03 |
4 |
D |
$100.46 |
$474,473 |
D/D |
(4,723) |
137,465 |
|
- |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-08-03 |
4 |
D |
$100.46 |
$2,372,363 |
D/D |
(23,615) |
313,040 |
|
- |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-08-01 |
4 |
D |
$92.25 |
$68,173 |
D/D |
(739) |
336,655 |
|
- |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-06-04 |
4 |
S |
$74.26 |
$58,588 |
D/D |
(789) |
142,188 |
|
-11% |
|
| Bolger John C |
Director |
– • – |
2021-06-03 |
4 |
S |
$74.17 |
$9,271 |
D/D |
(125) |
2,000 |
|
-18% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-06-02 |
4 |
S |
$71.34 |
$32,886 |
D/D |
(461) |
142,977 |
|
-10% |
|
| Bolger John C |
Director |
– • – |
2021-06-01 |
4 |
S |
$71.41 |
$133,966 |
D/D |
(1,876) |
2,125 |
|
-17% |
|
| Bolger John C |
Director |
– • – |
2021-06-01 |
4 |
OE |
$3.93 |
$22,824 |
D/D |
1,876 |
4,001 |
|
- |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-05-28 |
4 |
S |
$73.46 |
$47,527 |
D/D |
(647) |
337,394 |
|
-5% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-05-26 |
4 |
S |
$72.90 |
$1,312,119 |
D/D |
(18,000) |
143,438 |
|
-3% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-05-25 |
4 |
S |
$72.94 |
$755,479 |
D/D |
(10,358) |
161,438 |
|
-17% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-05-25 |
4 |
S |
$72.21 |
$144,412 |
D/D |
(2,000) |
338,041 |
|
-17% |
|
| Marsh Linda |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
|
- |
|
| Bolger John C |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,125 |
|
- |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-05-20 |
4 |
S |
$74.48 |
$74,480 |
D/D |
(1,000) |
340,041 |
|
-22% |
|
| Kim Paul |
CFO and Treasurer |
• – – |
2021-05-18 |
4 |
S |
$70.71 |
$81,670 |
D/D |
(1,155) |
171,796 |
|
-21% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-05-18 |
4 |
S |
$70.71 |
$65,831 |
D/D |
(931) |
341,041 |
|
-21% |
|
| Gao Hanlin |
Chief Scientific Officer |
• – – |
2021-05-18 |
4 |
S |
$70.71 |
$22,274 |
D/D |
(315) |
816,273 |
|
-21% |
|
| Xie Jian |
Chief Operating Officer |
• – – |
2021-05-01 |
4 |
D |
$77.02 |
$38,818 |
D/D |
(504) |
341,972 |
|
- |
|
281 Records found
|
|
Page 7 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.05 (0.23%) 
